Compare Stocks › ABBV vs PH

AbbVie Inc. (ABBV) vs Parker-Hannifin Corporation (PH): Which Is the Better Buy in 2026?

As of 2026-11-02, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. PH is fairly valued at $900, with an intrinsic value of $822 and a margin of safety of -9%. Of the two, PH has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
PH
Parker-Hannifin Corporation
$899.82

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
PH
  • ★Parker-Hannifin Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Parker-Hannifin Corporation scores 88/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • ★Free cash flow has grown at a 14.5% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
PH
  • ⚠PEG ratio of 3.01 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • ⚠10 insider sales totaling $18.6M with no purchases in the past 3 months — insiders are reducing their exposure.

Key Valuation Metrics

Learn more →
ABBV
PH
Valuation
N/A
Free Cash Flow
$3.90B
N/A
FCF Yield
3.44%
50.67
Trailing P/E
31.59
18.24
Forward P/E
22.63
Quality & Moat
29.08%
ROIC
16.50%
N/A
ROE
25.08%
73.72%
Gross Margin
37.55%
0.60
PEG Ratio
3.01
Balance Sheet Safety
N/A
Net Debt / Equity
0.53
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
1.45
2.35%
Dividend Yield
0.89%
ABBV: 5Ties: 1PH: 2
ABBVPH

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PH

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PH
$7.29
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$7.44B
Δ Market Cap
+$54.30B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PH
9.4% Overvalued
Price is 9.4% above estimated fair value
Current Price: $899.82
Fair Value: $822.35
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

PH

What growth rate is the market pricing in at $900?

+13.0%
Market-Implied Owner Earnings Growth
Standard FCF implies +13.8%

The market implies +13.0% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +13.8%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PH
88/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PH
-2.48
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PH
Insiders 0.2%Institutions 90.4%Retail & Other 9.4%
No. of Institutional Holders2,571
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
PH
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PH
10
Sells (3M)
27
Sells (12M)
Total value (12M): $49.75M
THOMPSON LAURA K
Director
$153,432
@ $958.95 · 2026-09-08
BRACHT BEREND
Officer
$626,363
@ $1040.47 · 2026-08-26
SCOTT PATRICK M.
Officer
$1.31M
@ $1057.00 · 2026-08-17
BRACHT BEREND
Officer
$738,521
@ $1055.03 · 2026-08-14
REIDY JAY
Officer
$316,731
@ $1055.77 · 2026-08-14
SCOTT PATRICK M.
Officer
$664,569
@ $1053.20 · 2026-08-14
ROSS ANDREW D.
President
$5.81M
@ $1057.57 · 2026-08-14
PAREL DINU JOHN
Chief Technology Officer
$4.73M
@ $1057.42 · 2026-08-14
HART MARK J
Officer
$2.64M
@ $1057.00 · 2026-08-14
VERRIER JAMES R.
Director
$1.59M
@ $1058.00 · 2026-08-14
BRACHT BEREND
Officer
$1.13M
@ $1002.13 · 2026-02-13
BENDALI RACHID
Officer
$414,777
@ $1006.74 · 2026-02-13
SCOTT PATRICK M.
Officer
$818,889
@ $983.06 · 2026-02-12
GENTILE THOMAS C.
Officer
$1.33M
@ $1001.51 · 2026-02-12
HART MARK J
Officer
$2.83M
@ $1009.12 · 2026-02-12
ROSS ANDREW D.
President
$4.66M
@ $999.00 · 2026-02-11
LEOMBRUNO TODD M.
Chief Financial Officer
$2.07M
@ $1002.34 · 2026-02-11
PARMENTIER JENNIFER A
Chief Executive Officer
$4.69M
@ $996.66 · 2026-02-11
BRACHT BEREND
Officer
$1.38M
@ $946.48 · 2026-02-02
JACOBSON MATTHEW A.
Officer
$535,766
@ $949.94 · 2026-02-02
PAREL DINU JOHN
Chief Technology Officer
$1.25M
@ $950.05 · 2026-02-02
GENTILE THOMAS C.
Officer
$2.24M
@ $941.31 · 2026-01-30
IVES ANGELA R
Officer
$1.02M
@ $952.30 · 2026-01-30
ROSS ANDREW D.
Chief Operating Officer
$2.23M
@ $894.81 · 2025-12-11
BRACHT BEREND
Officer
$3.03M
@ $864.58 · 2025-11-12
BENDALI RACHID
Officer
$1.23M
@ $852.99 · 2025-11-12
REIDY JAY
Officer
$337,675
@ $863.62 · 2025-11-12
VERRIER JAMES R.
Director
$1.13M
@ $750.00 · 2025-09-02
LEONTI JOSEPH R.
General Counsel
$3.47M
@ $750.84 · 2025-08-25
PAREL DINU JOHN
Chief Technology Officer
$817,477
@ $741.14 · 2025-08-12
BRACHT BEREND
Officer
$202,506
@ $728.44 · 2025-08-08
SCOTT PATRICK M.
Officer
$1.15M
@ $729.45 · 2025-08-08
JACOBSON MATTHEW A.
Officer
$421,510
@ $733.06 · 2025-08-08
MALONE ROBERT W
Officer
$1.65M
@ $730.66 · 2025-08-08
ROSS ANDREW D.
President
$3.20M
@ $732.66 · 2025-08-08
GENTILE THOMAS C.
Officer
$826,524
@ $729.50 · 2025-08-08
IVES ANGELA R
Officer
$589,162
@ $727.36 · 2025-08-08
HART MARK J
Officer
$1.65M
@ $730.22 · 2025-08-08
REIDY JAY
Officer
$335,783
@ $675.62 · 2025-05-19
REIDY JAY
Officer
$93,056
@ $620.37 · 2025-05-02
CZAJA MARK T.
Chief Technology Officer
$266,948
@ $711.86 · 2025-01-31
MALONE ROBERT W
Officer
$2.76M
@ $700.24 · 2024-11-06
ROSS ANDREW D.
Chief Operating Officer
$3.43M
@ $706.04 · 2024-11-06
GENTILE THOMAS C.
Officer
$1.70M
@ $701.16 · 2024-11-06
PAREL DINU JOHN
Officer
$1.23M
@ $699.39 · 2024-11-06
BRACHT BEREND
Officer
$1.08M
@ $699.29 · 2024-11-06
PARMENTIER JENNIFER A
Chief Executive Officer
$3.46M
@ $704.69 · 2024-11-06
HART MARK J
Officer
$2.79M
@ $705.40 · 2024-11-06
VERRIER JAMES R.
Director
$825,981
@ $635.37 · 2024-11-04
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PH
FearGreed
😐Neutral(47/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
PH
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (47)
View ABBV Full AnalysisView PH Full Analysis

Frequently Asked Questions: ABBV vs PH

Is AbbVie Inc. or Parker-Hannifin Corporation more undervalued in 2026?▼

Based on our discounted cash flow model, PH trades at a -9.4% margin of safety (intrinsic value $822 vs. price $900), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or Parker-Hannifin Corporation?▼

PH scores 88/100 (Wide moat), while ABBV scores 82/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. PH scores 6.8 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Parker-Hannifin Corporation?▼

ABBV earns 29.1% ROIC versus PH's 16.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Parker-Hannifin Corporation's?▼

PH's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). PH has raised its dividend for 3 consecutive years.